IRIS Accounts Production v24.3.0.553 12151848 Board of Directors Board of Directors 1.9.23 31.8.24 31.8.24 false true false false false 164707 61724 339768 151436 168739 48453 335736 164707 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh121518482023-08-31121518482024-08-31121518482023-09-012024-08-31121518482022-08-31121518482022-09-012023-08-31121518482023-08-3112151848ns15:EnglandWales2023-09-012024-08-3112151848ns14:PoundSterling2023-09-012024-08-3112151848ns10:Director12023-09-012024-08-3112151848ns10:Director22023-09-012024-08-3112151848ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3112151848ns10:Micro-entities2023-09-012024-08-3112151848ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3112151848ns10:FullAccounts2023-09-012024-08-3112151848ns10:Director2422023-08-3112151848ns10:Director2422022-08-3112151848ns10:Director2422023-09-012024-08-3112151848ns10:Director2422022-09-012023-08-3112151848ns10:Director2422024-08-3112151848ns10:Director2422023-08-3112151848ns10:RegisteredOffice2023-09-012024-08-3112151848ns5:CurrentFinancialInstruments2024-08-3112151848ns5:CurrentFinancialInstruments2023-08-3112151848ns5:Non-currentFinancialInstruments2024-08-3112151848ns5:Non-currentFinancialInstruments2023-08-31121518481ns10:Director12023-08-31121518481ns10:Director12022-08-31121518481ns10:Director12023-09-012024-08-31121518481ns10:Director12022-09-012023-08-31121518481ns10:Director12024-08-31121518481ns10:Director12023-08-31
REGISTERED NUMBER: 12151848 (England and Wales)

















Unaudited Financial Statements for the Year Ended 31 August 2024

for

Coelco Medical Limited

Coelco Medical Limited (by shares) (Registered number: 12151848)






Contents of the Financial Statements
for the Year Ended 31 August 2024




Page

Company Information 1

Balance Sheet 2


Coelco Medical Limited (by shares)

Company Information
for the Year Ended 31 August 2024







DIRECTORS: Dr C Girio-Fragkoulakis
Dr E Daniel





REGISTERED OFFICE: 2c Cavendish Street
Sheffield
S3 7RZ





REGISTERED NUMBER: 12151848 (England and Wales)





ACCOUNTANTS: SMH Haywood & Co Limited
24-26 Mansfield Road
Rotherham
South Yorkshire
S60 2DT

Coelco Medical Limited (by shares) (Registered number: 12151848)

Balance Sheet
31 August 2024

2024 2023
£    £   
FIXED ASSETS 31,501 39,375

CURRENT ASSETS 740,675 407,334

CREDITORS
Amounts falling due within one year (198,358 ) (53,578 )
NET CURRENT ASSETS 542,317 353,756
TOTAL ASSETS LESS CURRENT LIABILITIES 573,818 393,131

CREDITORS
Amounts falling due after more than one
year

(68,876

)

(42,725

)
NET ASSETS 504,942 350,406

CAPITAL AND RESERVES 504,942 350,406

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

2. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 August 2024 and 31 August 2023:

2024 2023
£    £   
Dr C Girio-Fragkoulakis and Dr E Daniel
Balance outstanding at start of year 164,707 61,724
Amounts advanced 339,768 151,436
Amounts repaid (168,739 ) (48,453 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 335,736 164,707



Coelco Medical Limited (by shares) (Registered number: 12151848)

Balance Sheet - continued
31 August 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 8 November 2024 and were signed on its behalf by:




Dr C Girio-Fragkoulakis - Director



Dr E Daniel - Director